Palladium-Catalyzed Cyanation of Arenediazonium Tetrafluoroborate Derivatives with 2-(Piperidin-1-yl)acetonitrile as the Cyano Source

Muhammad Siddique Ahmad; Zahid Shafiq; Kamel Meguellati

doi:10.1055/a-1770-8592

Synthesis, Inhaltsverzeichnis

Synthesis 2022; 54(13): 3077-3084
DOI: 10.1055/a-1770-8592

paper

Palladium-Catalyzed Cyanation of Arenediazonium Tetrafluoroborate Derivatives with 2-(Piperidin-1-yl)acetonitrile as the Cyano Source

Muhammad Siddique Ahmad ∗

^aSchool of Pharmacy, Jinan University, 855 Xingye Avenue East, Guangzhou, 511436, P. R. of China

,

Zahid Shafiq

^bInstitute of Chemical Sciences, Bhahauddin Zakariya University, Multan, 60800, Pakistan

,

Kamel Meguellati ∗

^aSchool of Pharmacy, Jinan University, 855 Xingye Avenue East, Guangzhou, 511436, P. R. of China

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

The present study describes the one-pot palladium-catalyzed cyanation of commercially available aryldiazonium tetrafluoroborate derivatives with 2-(piperidin-1-yl)acetonitrile (an organic cyano reagent) under mild conditions. This process utilizes a Pd/(Me₃Si)₂ system and is applied to a wide scope of aromatic diazonium substrates to give the corresponding nitrile-containing products in moderate to high yields (59–92%). This methodology is employed for the preparation of etravirine, a drug used for the treatment of HIV, and for transformations of 1H-indole-2-carbonitrile into compounds that are used as a NMDA receptor antagonists and that have high potential against mutant HIV strains. The mechanism proposed for this Pd-catalyzed cyanation involves cyanide ions, as confirmed using indicator paper.

Key words

C–CN cleavage - cyanation - Pd catalyst - coupling reaction - organic CN source

Volltext

Referenzen

References and Notes

For examples, see:

1a Kleemann A, Engel J, Kutschner B, Reichert D. Pharmaceutical Substances: Syntheses, Patents, Applications, 4th ed. Thieme; Stuttgart: 2001
1b Review: Miller JS, Manson JL. Acc. Chem. Res. 2001; 34: 563
1c Ahmad MS, Pulidindi IN, Li C. New J. Chem. 2020; 44: 17177
1d Anbarasan P, Schareina T, Beller M. Chem. Soc. Rev. 2011; 40: 5049

2a Sandmeyer T. Ber. Dtsch. Chem. Ges. 1884; 17: 1633
2b Kochi JK. J. Am. Chem. Soc. 1957; 79: 2942
2c Lindley J. Tetrahedron 1984; 40: 1433
2d Review: Hodgson HH. Chem. Rev. 1947; 40: 251
2e Barbero M, Cadamuro S, Dughera S. Org. Biomol. Chem. 2016; 14: 1437

For selected examples of NaCN as a CN source, see:

3a Cassar L. J. Organomet. Chem. 1973; 54: C57
3b Cassar L, Ferrara S, Foá M. Adv. Chem. Ser. 1974; 132: 252
3c Cassar L, Foá M, Montanari F, Marinelli GP. J. Organomet. Chem. 1979; 173: 335
3d Okano T, Iwahara M, Kiji J. Synlett 1998; 243
3e Dalton JR, Regen SL. J. Org. Chem. 1979; 44: 4443
3f Zanon J, Klarpars A, Buchwald SL. J. Am. Chem. Soc. 2003; 125: 2890
3g Ushkov AV, Grushin VV. J. Am. Chem. Soc. 2011; 133: 10999

For selected examples of KCN as a CN source, see:

4a Takagi K, Okamoto T, Sakakibara Y, Oka S. Chem. Lett. 1973; 471
4b Akita Y, Shimazaki M, Ohta A. Synthesis 1981; 974
4c Sakakibara Y, Okuda F, Shimobayashi A, Kirino K, Sakai M, Uchino N, Takagi K. Bull. Chem. Soc. Jpn. 1988; 61: 1985
4d Anderson BA, Bell EC, Ginah FO, Harn NK, Pagh LM, Wepsiec JP. J. Org. Chem. 1998; 63: 8224
4e Sundermeier M, Zapf A, Beller M, Sans J. Tetrahedron Lett. 2001; 42: 6707
4f Sundermeier M, Zapf A, Mutyala S, Baumann W, Sans J, Weiss S, Beller M. Chem. Eur. J. 2003; 9: 1828
4g Yang C, Williams JM. Org. Lett. 2004; 6: 2837
4h Cristau H.-J, Ouali A, Spindler J.-F, Taillefer M. Chem. Eur. J. 2005; 11: 2483

For selected examples of Zn(CN)₂ as a CN source, see:

5a Tschaen DM, Desmond R, King AO, Fortin MC, Pipik B, King S, Verhoeven TR. Synth. Commun. 1994; 24: 887
5b Maligres PE, Waters MS, Fleitz F, Askin D. Tetrahedron Lett. 1999; 40: 8193
5c Alterman M, Hallberg A. J. Org. Chem. 2000; 65: 7984
5d Jin F, Confalone PN. Tetrahedron Lett. 2000; 41: 3271
5e Ramnauth J, Bhardwaj N, Renton P, Rakhit S, Maddaford SP. Synlett 2003; 2237
5f Chidambaram R. Tetrahedron Lett. 2004; 45: 1441
5g Jensen RS, Gajare AS, Toyota K, Yoshifuji M, Ozawa F. Tetrahedron Lett. 2005; 46: 8645
5h Veauthier JM, Carson CN, Collis GE, Kiplinger JL, John KD. Synthesis 2005; 2683
5i Martin MT, Liu B, Cooley BE. Jr, Eaddy JF. Tetrahedron Lett. 2007; 48: 2555
5j Littke A, Soumeillant M, Kaltenbach RF, Cherney RJ, Tarby CM, Kiau S. Org. Lett. 2007; 9: 1711
5k Buono FG, Chidambaram R, Mueller RH, Waltermire RE. Org. Lett. 2008; 10: 5325
5l Cohen DT, Buchwald SL. Org. Lett. 2015; 17: 202
5m Zhang X, Xia A, Chen H, Liu Y. Org. Lett. 2017; 19: 2118

For selected examples of Me₃SiCN as a CN source, see:

6a Chatani N, Hanafusa T. J. Org. Chem. 1986; 51: 4714
6b Sundermeier M, Mutyala S, Zapf A, Spannenberg A, Beller M. J. Organomet. Chem. 2003; 684: 50

For examples using ‘non-metallic’ CN sources, see:

7a Review: Kim J, Kim HJ, Chang S. Angew. Chem. Int. Ed. 2012; 51: 11948
7b Gong TJ, Xiao B, Cheng WM, Su W, Xu J, Liu ZJ, Liu L, Fu Y. J. Am. Chem. Soc. 2013; 135: 10630
7c Yang Y, Buchwald SL. Angew. Chem. Int. Ed. 2014; 53: 8677
7d Wang L, Wang Y, Shen J, Chen Q, He M.-Y. Org. Biomol. Chem. 2018; 16: 4816
7e Zhang T, Qiao J, Song H, Xu F, Liu X, Xu C, Ma J, Liu H, Sun Z, Chu W. New J. Chem. 2019; 43: 9084
7f Iizumi K, Kurosawa MB, Isshiki R, Muto K, Yamaguchi J. Synlett 2021; 1555

For recent reviews on C–CN cleavage, see:

8a Najera C, Sansano JM. Angew. Chem. Int. Ed. 2009; 48: 2452
8b Kou X, Fan J, Tong X, Shen Z. Chin. J. Org. Chem. 2013; 33: 1407

9a Bollini M, Cisneros JA, Spasov KA, Anderson KS, Jorgenson WL. Bioorg. Med. Chem. Lett. 2013; 23: 5213
9b Joshi S, Maikap GC, Titirmare S, Chaudhari A, Gurjar MK. Org. Process Res. Dev. 2010; 14: 657

10 Fier PS, Hartwig JF. J. Am. Chem. Soc. 2014; 28: 10139

11a Borza I, Kolok S, Ignácz-Szendrei G, Greiner I, Tárkányi G, Galgóczy K, Horváth C, Farkas S, Domány G. Bioorg. Med. Chem. Lett. 2005; 15: 5439
11b Woodroofe CC, Meisenheimer PL, Klaubert DH, Kovic Y, Rosenberg JC, Behney CE, Southworth TL, Branchini BR. Biochemistry 2012; 51: 9807
11c Kou X, Zhao M, Qiao X, Zhu Y, Tong X, Shen Z. Chem. Eur. J. 2013; 19: 16880

For indicator strategies, see:

12a Kim J, Choi J, Shin K, Chang S. J. Am. Chem. Soc. 2012; 134: 2528
12b Zhang G, Ren X, Chen J, Hu M, Cheng J. Org. Lett. 2011; 13: 5004

13 Zhu Y, Zhou M, Luo W, Li L, Shen Z. Org. Lett. 2015; 17: 2602

14a Xu W, Xu Q, Li J. Org. Chem. Front. 2015; 2: 231
14b Zhang G, Zhang L, Hu M, Cheng J. Adv. Synth. Catal. 2011; 353: 291
14c Isobe T, Ishikawa T. J. Org. Chem. 1999; 64: 6984
14d Fang C, Li M, Hu X, Mo W, Hu B, Sun N, Jin L, Shen Z. RSC Adv. 2017; 7: 1484
14e O’Daniel PI, Peng Z, Pi H, Testero SA, Ding D, Spink E, Leemans E, Boudreau MA, Yamaguchi T, Schroeder VA, Wolter WR, Llarrull LI, Song W, Lastochkin E, Kumarasiri M, Antunes NT, Espahbodi M, Lichtenwalter K, Suckow MA, Vakulenko S, Mobashery S, Chang M. J. Am. Chem. Soc. 2014; 136: 3664
14f Liu Y.-Y, Liang D, Lu L.-Q, Xiao W.-J. Chem. Commun. 2019; 55: 4853
14g Kawagoe Y, Moriyama K, Togo H. Eur. J. Org. Chem. 2014; 19: 4115
14h Nicolaou KC, Mathison CJ. N. Angew. Chem. Int. Ed. 2005; 44: 5992
14i Mudshinge SR, Potnis CS, Xu B, Hammond GB. Green Chem. 2020; 22: 4161
14j Prabhu RN, Ramesh R. Tetrahedron Lett. 2017; 58: 405
14k Shimojo H, Moriyama K, Togo H. Synthesis 2013; 45: 2155
14l Reiner JE, Siev DV, Araldi G.-L, Cui JJ, Ho JZ, Komandla M, Mamedova L, Nolan TG, Semple JE. Bioorg. Med. Chem. Lett. 2002; 12: 1203
14m Choi S, Park C.-M, Park J, Sim J, Yu E. Angew. Chem. Int. Ed. 2020; 59: 11886
14n Wang Y, Huang W, Xin M, Chen P, Gui L, Zhao X, Wang J, Liu J. Bioorg. Med. Chem. 2017; 25: 75
14o Zhou S, Junge K, Addis D, Das S, Beller M. Org. Lett. 2009; 11: 2461

Zusatzmaterial

Supporting Information